Themis Bioscience Funding: $95M Raised, Series D (2019)
Themis Bioscience is based in Vienna, Austria. It has raised $95M in total funding. Latest round: Series D.
Themis Bioscience funding overview
Themis Bioscience is based in Vienna, Austria. Themis Bioscience has raised $95M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in September 2019. The round record for Themis Bioscience runs through 2019; nothing later has been disclosed. Investors on record include Merck Sharp & Dohme (MSD), Farallon Capital, Hadean Ventures, Global Health Investment Fund, Adjuvant Capital, aws Gruenderfonds and 3 others. 9 distinct backers are named across the disclosed rounds.
Themis Bioscience at a glance
Total raised
$95M
Latest round
Series D
Latest round date
September 2019
Headquarters
Vienna, Austria
Notable investors
Merck Sharp & Dohme (MSD), Farallon Capital, Hadean Ventures, Global Health Investment Fund, Adjuvant Capital, aws Gruenderfonds, Omnes Capital, Ventech
Frequently asked about Themis Bioscience funding
How much has Themis Bioscience raised?
Themis Bioscience has raised $95M in total disclosed funding across the rounds on record.
Who has invested in Themis Bioscience?
Merck Sharp & Dohme (MSD), Farallon Capital, Hadean Ventures, Global Health Investment Fund, Adjuvant Capital, aws Gruenderfonds are named among the investors backing Themis Bioscience.
What was the latest Themis Bioscience funding round?
The most recent disclosed round is a Series D, announced in September 2019.
Where is Themis Bioscience based?
Themis Bioscience is based in Vienna, Austria.
When did Themis Bioscience last raise?
The last disclosed Themis Bioscience round closed in September 2019 at Series D.
Totals shown for Themis Bioscience aggregate every disclosed round on file. To see how that compares, browse the companies in Vienna and the investors behind them below.
